Study to know the effect of some herbal drugs in the management of Irritable Bowel Syndrome (Grahani roga)

Phase 2

Conditions: Health Condition 1: null- Vatika Grahani (Irritable Bowel Syndrome)

Registration Number: CTRI/2018/03/012541

Lead Sponsor: ational Institute of Ayurveda

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Open to Recruitment

Sex: Not specified

Target Recruitment: 0

Inclusion Criteria

1 Patients willing to sign the consent form for trial

2 The patients aged between 16 â?? 70 years were selected

3 The patients having clinical signs and symptoms of Vatika Grahani and I B S as per Rome III criteria that is symptoms of recurrent abdominal pain or discomfort and a marked change in bowel habit for at least 6 months with symptoms experienced on at least 3 day/month in the last 3 months associated with two or more of the following

I Pain is relieved by defecation.

II Onset associated with change of frequency of stools

III Onset associated with change in form (appearance) of stools

Exclusion Criteria

1 Mixed infection with parasites like round worms, hook worms etc

2 Patients with bleeding per Rectum.

3 Patients with evidence of malignancy.

4 Patients having concomitant illness like HTN, DM-II, Amoebic dysentery, Ulcerative colitis, Malabsorption syndrome, Inflammatory Bowel Diseases & Intestinal tuberculosis, Lactase deficiency diarrhoea

5 Patients suffering from major systemic illness with corticosteroids, antidepressants, anticholinergics, or any other drugs that may have an influence on the outcome of the study

6 Alcoholics and drug abusers

7 Pregnant or lactating women

8 Patients who have completed participation in any other clinical trial during the past six months

Study & Design

Study Type: Interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Patients of either sex 16-70 yr old diagnosed with Grahani (Irritablle Bowel Syndrome) will be selected for relief in sign and symptoms.Timepoint: 30 days

Secondary Outcome Measures